The market for cloflufenazole is growing rapidly, and the number of related patents continues to increase.

Cloflufenconazole (trade name: Revysol, RuiShou, etc.) is a new type of isopropyl alcohol triazole fungicide. Cloflufenazole acts on the C14-demethylase in the sterol biosynthesis process of the cell membrane of pathogenic bacteria. By preventing the biosynthesis of ergosterol, it causes the collapse of the cell membrane, thereby inhibiting the growth of pathogenic cells. Cloflufenazole has the characteristics of broad spectrum, high efficiency, safety and long-lasting effect. It has protective, therapeutic and eradication effects. Since its launch, cloflufenazole has been favored by the market.

Cloflufenazole was developed by BASF and successfully launched in 2018. The launch of pyraclostrobin has filled the gap of no new triazole fungicides in the past ten years, so it has attracted market attention. In 2019, The global annual sales of pyraclostrobin exceed US$1 billion, making it the second largest fungicide in the world. Cloflufenazole is highly safe and has successively obtained green and safety grade certifications from the European Union, the United States, Australia and other regions.

At present, cloflufenicon has been registered and marketed in many countries and regions, including South Korea, the United States, Australia, China, etc., and its applicable crops involve more than 60 crops such as corn, rice, fruit trees, vegetables, and soybeans. Cloflufenazole is suitable for a wide range of crops, and its global registration covers almost all major crops. In terms of dosage forms, the approved dosage forms of cloflufenconazole include emulsifiable concentrate (EC), suspension concentrate (SC), seed treatment suspension concentrate (FS), etc.

According to the “2022-2027 China Fluorotriazole Industry Market In-depth Research and Development Prospects Forecast Report released by the Industrial Research Center It shows that in China, the registered categories of cloflufeniconazole are all fungicides. The registered companies are BASF Plant Protection (Jiangsu) Co., Ltd. and BASF Europe. The registered dosage forms include suspension concentrate and original drug. In terms of compound products, cloflufenac can be compounded with pyraclostrobin, triflufenac and other products.

Cloflufenconazole has attracted much market attention, currently including BASF, Bayer, Syngenta, Nippon Kayaku Co., Ltd., Sumitomo Chemical Co., Ltd., Jiangxi Zhengbang Crops, Shenzhen Nopusin Agrichemical Co., Ltd., and Guangdong Academy of Agricultural Sciences Plant Protection Research Nearly 40 companies or individuals, including the Institute, have applied for cloflufenazole-related patents, involving composition patents, compound patents, preparation patents, use patents, crystal form patents, application method patents, etc.

Industry analysts said that cloflufenconazole is a triazole fungicide. With its advantages of broad spectrum, high efficiency and safety, Cloflufenconazole has attracted market attention since its launch, and market sales have continued to grow. At present, cloflumiconazole has been registered and marketed in many countries around the world. At the same time, with BASF’s active promotion and rising market demand, the global cloflumiconazole consumer market is expected to further expand.